Researchers from MIT and Scripps have unveiled a promising new HIV vaccine approach that generates a powerful immune response ...

Health authorities in Zambia have halted a planned clinical trial for an HIV vaccine after the United States withdrew funding ...

The approach employed by the research team could be used against other diseases—including COVID-19 and influenza.

The breakthrough double injection won’t be cheap in the US, although scientists argue it could (and should) be.

Researchers from MIT and Scripps have unveiled a promising new HIV vaccine approach that generates a powerful immune response ...

By C.J. Atkins Just in time for Pride month, President Donald Trump and Health Secretary Robert F. Kennedy, Jr., have ...

Researchers at MIT and the Scripps Research Institute have shown that they can generate a strong immune response to HIV with ...

The US Food and Drug Administration (FDA) has approved use of the vaccine Yeztugo, manufactured by Gilead Sciences, is an anti-HIV drug.

The approval could slow new infections and move the world closer to eliminating HIV. But huge obstacles remain.

In the quest to develop an effective HIV vaccine, scientists from Scripps Research have made a significant leap forward. They ...

Experts and advocates say that twice-a-year HIV PrEP injections have the prevention potential of a vaccine — and that a once-a-year version of lenacapavir would be even better. But will Yeztugo be ...

There is still no cure or effective vaccine for HIV, but scientists have opened up new possibilities in HIV treatment and ...